Executive pay
Recursion Pharmaceuticals (RXRX) executive compensation
What Recursion Pharmaceuticals, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.
- 2026 proxy statement
Christopher Gibson paid $9.6M (+13% on the year), pay ratio 33:1.
Filed Apr 30, 2026